Expression of human cytomegalovirus pp150 gene in transgenic Vicia faba L. and immunogenicity of pp150 protein in mice

Biologicals

Volumn 38, Issue 2, 2010, Pages 265-272

  Yan, Hua ^a   Yan, Huishen ^b   Li, Guocai ^a   Gong, Weijuan ^a   Jiao, Hongmei ^a   Chen, Hongju ^a   Ji, Mingchun ^a  

^a YANGZHOU UNIVERSITY   (China)

^b Department of Medical Science   (China)

Author keywords

Edible vaccine; HCMV pp150; Immunogenicity; Vicia faba

Indexed keywords

EDIBLE VACCINE; GAMMA INTERFERON; HYGROMYCIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHOPROTEIN 150; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOT HYBRIDIZATION; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE TRANSFER; GENETIC TRANSFORMATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; MOUSE; NONHUMAN; PLANT LEAF; PLANT SEED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHIZOBIUM RADIOBACTER; TRANSGENIC PLANT; VACCINE PRODUCTION; VICIA FABA;

ANIMAL FEED; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED BALB C; PHOSPHOPROTEINS; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; SEEDS; TRANSFORMATION, GENETIC; VACCINES, SYNTHETIC; VICIA FABA; VIRAL MATRIX PROTEINS;

AGROBACTERIUM TUMEFACIENS; HUMAN HERPESVIRUS 5; MUS; VICIA FABA;

EID: 77950689640     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.11.005     Document Type: Article

References (38)

1. Das S., Pellett P.E. Members of the HCMV US12 family of predicted heptaspanning membrane proteins have unique intracellular distributions, including association with the cytoplasmic virion assembly complex. Virol 2007, 361:263-273.
2. Favacho A.R.M., Cintra E.A., Coelho L.C.B.B., Linhares M.I.S. In vitro activity evaluation of Parkia pendula seed lectin against human cytomegalovirus and herpes virus 6. Biologicals 2007, 35:189-194.
3. Brondke H., Schmitz B., Doerfler W. Nucleotide sequence comparisons between several strains and isolates of human cytomegalovirus reveal alternate start codon usage. Arch Virol 2007, 152:2035-2046.
4. Yan H., Li G.C., Yan H.S., Chen H.J., Gong W.J., Qian L., et al. Establishment and characterization of a novel genetic hybrid cell line for propagation of four pathogens. J Virol Methods 2006, 134:86-91.
5. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990, 154:125.
6. Jahn G., Scholl B.C., Traupe B., Fleckenstein B. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol 1987, 68:1327-1337.
7. Müller T.F., Gicklhorn D., Jungraithmayr T., Eickmann M., Lange H., Radsak K., et al. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients. J Clin Virol 2002, 24:45-56.
8. Aucoin D.P., Smith G.B., Meiering C.D., Mocarski E.S. Betaherpesvirus conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol 2006, 80:8199-8210.
9. Beghetto E., Paolis F.D., Spadoni A., Porto P.D., Buffolano W., Gargano N. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display. J Virol Methods 2008, 151:7-14.
10. Rosa C.L., Wang Z., Lacey S.F., Markel S.F., Sharma M.C., Martinez J., et al. Characterization of host immunity to cytomegalovirus pp150 (UL32). Human Immunol 2005, 66:116-126.
11. Gyulai Z., Endresz V., Burian K., Pincus S., Toldy J., Cox W.I., et al. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTL. J Infect Dis 2000, 18:1537-1546.
12. Wang Z., Zhou W., Srivastava T., Rosa C.L., Mandarino A., Forman S.J., et al. A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector. Virol 2008, 377:379-390.
13. Curtiss RI, Cardineau CA. Oral immunisation by transgenic plants. World Patent Application WO 90/02484; 1990.
14. Sala F., Rigano M.M., Barbante A., Basso B., Walmsley A.M., Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine 2003, 21:803-808.
15. Tackaberry E.S., Dudani A.K., Prior F., Tocchi M., Sardana R., Altosaar I., et al. Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 1999, 17:3020-3029.
16. Li G.C., Yan H., Ji M.C., Jiao H.M., Wang B. Cloning and prokaryotic expression of antigenic determinants of pp150 of human cytomegalovirus and its preliminary application. J Virol 2004, 20:169-171. (in Chinese).
17. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987, 196:947-950.
18. Wydro1 M., Kozubek E., Lehmann P. Optimization of transient Agrobacterium-mediated gene expression system in leaves of Nicotiana benthamiana. Acta Biochim Pol 2006, 53:289-298.
19. Murashige T., Skoog F. A revised medium for rapid growth and bioassays with Vicia faba tissue cultures. Physiol Plant 1962, 15:473-497.
20. Jelenć S., Mitrikeski P.T., Papeš D., Jelaska S. Agrobacterium-mediated transformation of Broad Bean Vicia faba L. Food Technol Biotechnol 2000, 38(3):167-172.
21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1996, 72:248-254.
22. Yan H., Hf Shen, Li G.C. Identification of McAb against different HCMV polypeptides. J Immunol 2000, 16:297-299.
23. Berinstein A., Vazquez-Rovere C., Asurmendi S., Gomez E., Zanetti F., Zabal O., et al. Mucosal and systemic immunization elicited by Newcastle Disease Virus (NDV) transgenic plants as antigen. Vaccine 2005, 23:5583-5589.
24. Li G.C., Yan H., Ji M.C., Shen H.F., Chen H.J., Jiao H.M., et al. Cloning and prokaryotic expression of antigenic determinants of pp150 of human cytomegalovirus and its preliminary application. Chinese J Virol 2004, 20(2):169-171.
25. Navalpotro D., Gimeno C., Navarro D. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients. J Clin Virol 2006, 35:193-196.
26. Yuan L., Ward L.A., Rosen B.I., To T.L., Saif L.J. Systematic and intestinal antibody secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol 1996, 70:3075-3083.
27. Ward L.A., Rosen B.I., Yuan L., Saif L.J. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 1996, 77:1431-1441.
28. Yuan L., Wen K., Azevedo M., Gonzalez A., Zhang W., Saif L. Virus-specific intestinal IFN-γ producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs. Vaccine 2008, 26:3322-3331.
29. Wang Z., Rosa C.L., Lacey S.F., Maas R., Mekhoubad S., Britt W.J., et al. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. J Clin Virol 2006, 35:324-331.
30. Yan H., Pan X.B. Actualities on the production of subunit vaccine from pathogenic microorganisms in transgenic plants. Foreign Med Sci (Microbiol) 2005, 28:18-28.
31. Guetard D., Greco R., Cervantes-Gonzalez M., Celli S., Kostrzak A., Langlade-Demoyen P., et al. Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration. Vaccine 2008, 26(35):4477-4485.
32. Khandelwal A., Renukaradhya G.J., Rajasekhar M., Sita G.L., Shaila M.S. Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model. Virol 2004, 323:284-291.
33. Modelska A., Dietzschold B., Sleysh N., Fu Z.F., Steplewski K., Hooper D.C., et al. Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci U S A 1998, 95:2481-2485.
34. Kim T.G., Ruprecht R., Langridgea W.H.R. Synthesis and assembly of a cholera toxin B subunit SHIV 89.6p Tat fusion protein in transgenic potato. Protein Expres Purif 2004, 35:313-319.
35. Kim T.G., Ruprecht R., Langridge W.H.R. SIVmac Gag p27 capsid protein gene expression in potato. Protein Expres Purif 2004, 36:312-317.
36. Kim T.G., Langridge W.H.R. Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic tomato. Plant Cell Rep 2003, 21:884-890.
37. Kim T.G., Gruber A., Langridgea W.H.R. HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expres Purif 2004, 37:196-202.
38. Yu J., Langridge W. Expression of rotavirus capside protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res 2003, 12:163-169.